Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $459.85 | Total: $2,299.25 |
| 1 | 10 | $389.52 | Total: $3,895.20 |
| 1 | 25 | $330.01 | Total: $8,250.25 |
| 1 | 50 | $281.32 | Total: $14,066.00 |
| 1 | 100 | $243.45 | Total: $24,345.01 |
Overview
Cap-dependent endonuclease-IN-1 is a highly potent, orally active cap-dependent endonuclease inhibitor with antiviral activity for studying influenza virus infection.
Chemical Properties
| Molecular Formula | C27H22F2N2O6S |
| Molecular Weight | 540.54 |
| CAS Numbers | 2365473-17-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1C2(CN(N3C1=C(OCOC(OC)=O)C(=O)C=C3)[C@H]4C=5C(CSC=6C4=CC=CC6)=C(F)C(F)=CC5)CC2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Ming-Chu Hsu, et al. Cap-dependent endonuclease inhibitors. WO2019144089A1.